GF
AMED

Gerstein Fisher’s Amedisys AMED Stock Holding History

Gerstein Fisher’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4.36M Buy
91,976
+688
+0.8% +$34.3K 0.54% 33
2016
Q2 		$4.61M Buy
91,288
+19,798
+28% +$999K 0.6% 27
2016
Q1 		$3.46M Buy
71,490
+20,922
+41% +$807K 0.47% 34
2015
Q4 		$1.99M Hold
50,568
– – 0.28% 69
2015
Q3 		$1.92M Buy
+50,568
New +$2.13M 0.29% 66

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Gerstein Fisher's AMED Position: Q3 2016 in Review

Gerstein Fisher increased its Amedisys (AMED) stake by 0.75% in Q3 2016, buying an estimated $34.3K and bringing the position to 91,976 shares worth $4.36M. The position accounts for 0.54% of the portfolio, ranked #33.

Gerstein Fisher first reported a position in AMED in Q3 2015 and has held it in 5 quarters since. The position peaked at $4.61M in Q2 2016. 154 funds tracked by Wall St. Rank hold AMED as of Q3 2016.

  • Gerstein Fisher held 91,976 shares of Amedisys worth $4.36M as of Q3 2016.
  • Gerstein Fisher bought 688 Amedisys shares in Q3 2016, an estimated $34.3K.
  • Amedisys made up 0.54% of Gerstein Fisher's portfolio in Q3 2016, its #33 holding.
  • Gerstein Fisher first reported a position in Amedisys in Q3 2015 and has held it in 5 quarters since.
  • Gerstein Fisher's Amedisys position peaked at $4.61M in Q2 2016.
  • 154 funds tracked by Wall St. Rank held Amedisys as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.